IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
CA2158040A1
(en)
*
|
1993-03-11 |
1994-09-15 |
Jacqueline D. Duncan |
Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
|
WO1995011700A1
(en)
*
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
GB9417742D0
(en)
*
|
1994-09-03 |
1994-10-19 |
Univ Nottingham |
Macrophage stimulating composition
|
BE1008977A5
(fr)
*
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
US5891393A
(en)
*
|
1996-04-09 |
1999-04-06 |
The University Of North Carolina At Chapel Hill |
Method for the microbial decontamination of blood platelets
|
GB9622159D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
US6416779B1
(en)
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
US6197327B1
(en)
*
|
1997-06-11 |
2001-03-06 |
Umd, Inc. |
Device and method for treatment of dysmenorrhea
|
US6572874B1
(en)
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
FR2775601B1
(fr)
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
FR2776928B1
(fr)
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
WO2000056361A2
(en)
*
|
1999-03-24 |
2000-09-28 |
The Secretary Of State For Defence |
Vaccine composition
|
US6943152B1
(en)
*
|
1999-06-10 |
2005-09-13 |
Merial |
DNA vaccine-PCV
|
MY129765A
(en)
|
2000-12-19 |
2007-04-30 |
Wyeth Corp |
Improved mycoplasma hyopneumoniae bacterin vaccine
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
WO2004064759A2
(en)
|
2003-01-21 |
2004-08-05 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
CA2520124A1
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of benzazole compounds for immunopotentiation
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
免疫増強用の化合物
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
WO2007079147A2
(en)
|
2005-12-28 |
2007-07-12 |
Advanced Bionutrition Corporation |
A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
EP2371386A1
(en)
|
2005-12-29 |
2011-10-05 |
Boehringer Ingelheim Vetmedica, Inc. |
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
|
UA99708C2
(ru)
|
2005-12-29 |
2012-09-25 |
Берингер Ингельхайм Ветмедика, Инк. |
Одноразовая доза поливалентной комбинированной вакцины, которая включает антиген цирковируса свиней типа 2
|
CA2647100A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Methods for the preparation of imidazole-containing compounds
|
WO2007109812A2
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
EP2357184B1
(en)
|
2006-03-23 |
2015-02-25 |
Novartis AG |
Imidazoquinoxaline compounds as immunomodulators
|
WO2008073464A2
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
*
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
BRPI0907438A2
(pt)
|
2008-01-23 |
2015-08-04 |
Boehringer Ingelheim Vetmed |
Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
|
KR101687841B1
(ko)
|
2008-12-09 |
2016-12-19 |
길리애드 사이언시즈, 인코포레이티드 |
톨-유사 수용체의 조절제
|
US9603919B2
(en)
*
|
2009-03-31 |
2017-03-28 |
Japan As Represented By The Director-General Of National Institute Of Infectious Diseases |
Method for prophylaxis of influenza using vaccine for intranasal administration
|
JP5841527B2
(ja)
|
2009-05-26 |
2016-01-13 |
アドバンスド バイオニュートリション コーポレーション |
生物学的に活性な微生物および/または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法
|
PH12012501410A1
(en)
|
2010-01-28 |
2012-10-22 |
Advanced Bionutrition Corp |
Dry glassy composition comprising a bioactive material
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
WO2013138334A1
(en)
|
2012-03-12 |
2013-09-19 |
Advanced Bioadjuvants, Llc |
Adjuvant and vaccine compositions
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
WO2015051099A1
(en)
|
2013-10-02 |
2015-04-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Pcv2 orf2 protein variant and virus like particles composed thereof
|
WO2016001907A1
(en)
|
2014-07-02 |
2016-01-07 |
Prendergast Patrick T |
Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
|
CA2994112C
(en)
|
2015-07-29 |
2023-08-08 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
AR114911A1
(es)
|
2018-06-04 |
2020-10-28 |
Apros Therapeutics Inc |
Conjugados peptídicos de tlr7
|
BR112020026989A2
(pt)
|
2018-07-02 |
2021-03-30 |
Ayuvis Research, Inc. |
Novas pequenas moléculas de imunomodulação
|